We report the cloning and characterization of the entire AFX gene which fuses to MLL in acute leukemias with a t(X;11)(q13;q23). AFX consists of two exons and encodes for a protein of 501 amino acids. We found that normal B-and T-cells contain similar levels of AFX mRNA and that both the MLL/AFX as well as the AFX/MLL fusion transcripts are present in the cell line and the ANLL sample with a t(X;11)(q13;q23). The single intron of the AFX gene consists of 3706 nucleotides. It contains ®ve simple sequence repeats with lengths of at least 12 bps, a chi-like octamer sequence (GCA/TGGA/TGG) and several immunoglobulin heptamer-like sequences (GATAGTG) that are distributed throughout the entire AFX intron sequence. In the KARPAS 45 cell line the breakpoints occur at nucleotides 2913/2914 of the AFX intron and at nucleotides 4900/4901 of the breakpoint cluster region of the MLL gene. The AFX protein belongs to the forkhead protein family. It is highly homologous to the human FKHR protein, the gene of which is disrupted by the t(2;13)(q35;q14), a chromosome rearrangement characteristic of alveolar rhabdomyosarcomas. It is noteworthy that the t(X;11)(q13;q23) in the KARPAS 45 cell line and in one acute nonlymphoblastic leukemia (ANLL) disrupts the forkhead domain of the AFX protein exactly at the same amino acids as does the t(2;13)(q35;q14) in case of the FKHR protein. In addition, the 5'-part of the AFX protein contains a conserved hexapeptide motif (QIYEWM) that is homologous to the functionally important conserved hexapeptide QIYPWM upstream of the homeobox domain in Hox proteins. This motif mediates the co-operative DNA binding of Pbx family members and Hox proteins and, therefore, plays an important role in physiologic and oncogenic processes. In acute leukemias with a t(X;11)(q13;q23), this hexapeptide motif is separated from the remaining forkhead domain within the AFX protein. The predicted amino acid sequence of AFX diers signi®cantly from the partial AFX protein sequence published previously (Genes, Chromosomes and Cancer, 1994, 11, 79 ± 84). This discrepancy can be explained by the occurrence of two sequencing errors in the earlier work at nucleotide number 783 and 844 (loss of a cytosine residue or guanosine residue, respectively) that lead to two reading frame shifts.
Introduction
The identi®cation and characterization of genes that are involved in neoplasm-speci®c karyotype abnormalities provide important insights into their normal function and their role in the transformation process (for review see Rabbitts, 1994) . In acute leukemias at least 29 dierent chromosome translocations aect the region 11(q23) (Rowley, 1993) . The vast majority of these breaks disrupt the mixed-lineage leukemia (MLL) gene within a small region of 8.6 kb (McCabe et al., 1992) and fuse it to a variety of dierent partner genes. To date, at least 10 of these fusion partners have been identi®ed and molecular genetically characterized (Rowley, 1993) . Moreover, a partial tandem duplication of the MLL gene occurs in both leukemias and in a cell line derived from a solid tumour. Baa et al., 1995) . The MLL protein shares regions of signi®cant similarity with the trithorax protein of Drosophila melanogaster, such as zinc®nger motifs and a highly homologous region at the carboxy-terminus of the MLL protein (Gu et al., 1992; Tkachuk et al., 1992) . The partner genes also contain various structural motifs that are commonly found in transcription factors, such as zinc ®ngers and leucinezippers in the AF10 and the AF17 genes, nuclear target sequences and consensus sequences for ATP/GTPbinding in the AF4 and ENL genes and alpha-helical and coiled-coil-domains for protein-protein interaction in the AF1p gene (Chaplain et al., 1995a; Prasad et al., 1994; Nakamura et al., 1993; Bernard et al., 1994) .
Several partner genes on chromosomes 1, 4, 6, 9, 10, 17 and two genes on chromosome 19 are cloned and entirely sequenced. Since only parts of the AFX gene involved in the t(X;11)(q13;q23) have been characterised (Corral et al., 1993; Parry et al., 1994) , we decided to clone this gene and to complete its sequence. To further elucidate the molecular basis for the t(X;11)(q13;q23), we also sequenced the single intron of the AFX gene and analysed its breakpoint in the KARPAS 45 cell line.
Results

Isolation of AFX cDNA and exon/intron structure of AFX
We used the partial cDNA sequence of AFX to clone the entire AFX gene by a 5'-and 3' rapid ampli®cation of cDNA ends polymerase chain reaction (RACE RT-PCR) approach (Frohman et al., 1988) . We sequenced overlapping clones in both directions. Compilation of sequence data established a 3171 nucleotide consensus sequence. It includes a polyadenylation-site (AA-TAAA) that starts at nucleotide 3102 (Figure 1 ). Repeated PCR experiments did not reveal additional 5'-sequences. Thus, it seems unlikely that the AFX gene extends further upstream. The sequence surrounding the inframe initiating codon starting at nucleotide 183, namely, GGGAATGA, does not perfectly correspond to the consensus sequence CACCATGG which otherwise is required for optimal initiation by eukaryotic ribosomes (Kozak, 1991) . Nevertheless, after 147 amino acids the open reading frame matches with the partial sequence previously published by Corral et al. (1993) . The existence of a purine at position 73 that is essential for translation, further substantiates the deduced amino acid sequence shown in Figure 1 . The calculated molecular mass of the AFX protein is 53 kDa. The AFX protein is rich in serine (13%), proline (12%) and leucine (10.5%) residues. These amino acids comprise more than one third of the total protein.
Determination of the exon/intron structure of the AFX gene with cDNA and genomic DNA as a template for the ampli®cation of dierent parts of the gene, revealed that it consists of two exons and of an interspersed intron with 3706 bps (Figure 2) . In DNA data banks we found two unpublished clones (Accession numbers T54418 or T54462, respectively) CAATAAATGA Figure 1 Nucleotide sequence and amino acid sequence of AFX. The fusion point with the MLL protein is indicated by an arrow. The forkhead domain is underlined. The sequence was deposited in the EMBL database (Accession number X93996). The polyadenylation signal is italicized and underlined within the AFX cDNA sequence that are identical with the nucleotides 2708 ± 3012 (plus strand, T54418) and nucleotide 3131 ± 2813 (minus strand, T54462) of the 3'-untranslated region of the AFX sequence. According to the available Genebank information, these two clones derive from a placental tissue and were recovered during a sequencing project dealing with chromosomal region Xq13. (WashUMerck EST project, Wilson et al., Washington University of Medicine, USA).
Con®rmation of the chromosomal localisation of AFX gene at Xq13
To con®rm the chromosomal location of our AFX clone, we hybridized a mixture of ®ve pooled AFX clones that contained nucleotides 624 ± 3000 of the AFX cDNA onto normal metaphase cells. As expected, the AFX probe mapped to X(q13) (Figure 3) .
Expression of AFX mRNA in normal B-and T-cells
We analysed the expression pattern of the AFX gene in B-and T-lymphocytes for three reasons. First, human hematopoietic cells express forkhead genes in a lineage-restricted manner (Hromas et al., 1993) . Second, the KARPAS 45 cell line with a translocation t(X;11)(q13;q23) and a MLL/AFX gene fusion derives from a pediatric acute T-cell leukemia, and MLL involvement in this particular subtype is being rather unusual (Chervinsky et al., 1995) . Third, like AFX, the human T-cell leukemia virus enhancer factor (HTLF) is also a member of the forkhead gene family (Li et al., 1992) . Using as semiquantitative RT-PCR with primers located in exon 1 and exon 2 of AFX we did, however, not ®nd a distinct signal intensity in equivalent amounts of B-or T-lymphocytes (Figure 4) .
Detection of both MLL/AFX and AFX/MLL chimeric mRNA in the KARPAS-45 cell line and in an ANLL with a t(X;11)(q13;q23)
Using primers that¯ank the RNA's fusion points in the two hybrid gene products we detected chimeric mRNAs from both the derivative chromosomes X and 11 in the cell line KARPAS 45 as well as in a case of infant ANLL with the respective translocation ( Figure  5 ). Sequence analysis con®rmed that both PCR products consisted of fused parts of MLL and AFX.
Sequencing of AFX intron 1 and sequence analysis of the breakpoint region in the KARPAS-45 cell line
The entire intron 1 of AFX consists of 3706 nucleotides ( Figure 6 ). It contains 5 simple sequence repeats with length of at least 12 bps, a chi-like octamer sequence (GCA/TGGA/TGG) and several immunoglobulin heptamer-like sequences (GA-TAGTG) that are distributed throughout the entire AFX intron sequence (Table 1) . We analysed the breakpoints in the Karpas 45 cell line by sequencing ampli®ed genomic DNA of the MLL/AFX fusion region. In the AFX intron the breakpoint occurred at nucleotides 2913/2914 ( Figure 6 ) and in the MLL gene within the established breakpoint cluster region at nucleotides 4900/4901 .
The AFX protein is highly homologous to the human forkhead protein FKHR
The AFX protein has no signi®cant amino acid homology to the other MLL partner proteins known so far. However, a search of the PROSITE database revealed the presence of a forkhead domain in the middle of the AFX protein (amino acids 95 ± 196) . This domain is 80% homologous to that of the human FKHR gene. Moreover, several other members of the forkhead family of eukaryotic transcription factors are partially homologous to the AFX protein ( Figure 7 ). However, except for AFX and FKHR, which also share 19 of 21 amino acids at their amino-terminal parts, all other transcription factors dier remarkably outside this highly conserved forkhead region. Two small parts of this motif (amino acids 15 ± 35 of the AFX protein and 11 ± 31 of the FKHR protein, respectively) are also partially homologous to the mouse and rat neural cell adhesion molecule (N-CAM; data not shown). In addition, the amino acids 122 ± 128 of the AFX protein (QIYEWMV) strikingly resemble the conserved peptide motify QIYPWMK that is located upstream of the homeobox domain the antennapedia class of HOX/HOM proteins ( Figure 1) . A protein (a) Lane 1: molecular weight marker VI (pBR328 DNA/Bg1I+ pBR328 DNA/HinfI, Boehringer, Mannheim, Germany); lane 13: molecular weight marker III (DNA/HindIII+ EcoRI, Boehringer, Mannheim, Germany); lanes 2, 7 and 8: negative controls in which the template had been replaced by sterile water; lanes 3 ± 6: PCR products obtained with primers A1 and A2 from exon 1 of the AFX gene. As template we used cDNA and genomic cDNA from the HL60 promyelocytic cell line (lanes 3 and 4) and a healthy volunteer (lanes 5 and 6). Identical length of PCR products indicates the lack of intron sequences. In case cDNA (lanes 9 and 10) and genomic DNA (lanes 11 and 12) from the same source is ampli®ed with primers B1 and B2 the length dierences of the PCR products reveal the presence of a 3706 bp intron. Lanes 14 ± 17 show the PCR products obtained with primers C1 and C2 that are located in exon 2. They remain of the same size irrespective of the source of the template (cDNA: lanes 14 and 15: genomic DNA: lanes 16 and 17). (b) Schematic presentation of the exon/intron structure of the AFX gene together with the positions of the PCR primers block data base search with the BLIMPS package programme (EMBL, Heidelberg, Germany) revealed that the amino acids 204 ± 231 and 411 ± 445 of the AFX protein are partially homologous to the protein neuraxin which seems to be responsible for neuronal membrane microtubule interactions (Rienitz et al., 1989) . At the amino-terminal part of AFX, amino acids 87 ± 121 are similar to the myb DNA-binding domain proteins (Introna et al., 1994) .
Discussion
In the present paper we report the cloning and sequencing of the entire AFX gene. This gene fuses ¨ ¨F igure 5 Both the MLL/AFX and the AFX/MLL fusion mRNA are found in the KARPAS 45 cell line (lanes 4 and 6) and in a sample from an infant with ANLL and a t(X;11)(lanes 5 and 7). In lanes 9 and 10 the MLL/AFX and AFX/MLL genomic DNA fusions are seen. The fragments were ampli®ed from the KARPAS 45 cell line. Subsequently, we used these fragments to de®ne the genomic breakpoints within the MLL and AFX gene. In lanes 1 and 11 the molecular weight markers VI and III (Boehringer, Mannheim, Germany) are shown. Lanes 2, 3 and 8 contain negative control ampli®cations Figure 3 The 2.4 kb AFX maps to X(q13): a normal, DAPI-stained metaphase (top left) and its reversed image that facilitates identi®cation of the individual chromosomes (top right). X-chromosome from several metaphases (bottom row) to MLL in acute leukemias with a t(X;11)(q13;q23). In accordance with the other MLL partner proteins AF4, AF9, AF10 and ENL, the AFX protein has a high content of serine and proline, a feature that is commonly found in transcriptional activators (Theill et al., 1989) . Using the sequence alignment methodology, we not only con®rm that AFX is a member of the forkhead gene family (Parry et al., 1994) , but also show that it has a signi®cant homology to the FKHR gene outside the forkhead domain at the aminoterminal part. Moreover, one stretch of the AFX protein is also highly homologous to a short motif that is conserved in the aminoterminal part of many homeotic Hox proteins. The proteins encode by the Hox gene complex are members of a large family of vertebrate transcription factors. They confer positional identity through the dierential expression of their target genes during embryonic development (Deschamps et al., 1992) . The Hox proteins contain a homeobox domain with an extremely well conserved region of 60 ± 61 amino acids that is responsible for sequence speci®c DNA binding (Gehring et al., 1994) . For the sucient biological activity, however, the DNA binding of Hox proteins requires several individual interactions with other proteins. At least in cases of Hox-Pbx interactions, it is the IYPWMK motif that mediates these protein-protein interactions (Phelan et al., 1995) . The gene encoding for the Pbx protein was originally discovered by cloning the chromosomal translocation t(1;19) in pre-B ALL (Kamps et al., 1990) . Hox proteins that lack this hexapeptide motif, such as HoxA10, do not bind co-operatively DNA with Pbx, whereas the engraftment of the hexapeptide by side directed mutagenesis to HoxA10 provides the ability for co-operative DNA binding (Chang et al., 1995) . On the other hand, the co-operation of Pbx-related genes with Hox genes can initiate leukemias in a murine system (Nakamura et al., 1996) . The presence of a similar functionally important hexapeptide motif within the AFX forkhead protein suggests that in leukemias with a t(X;11) the separation of the hexapeptide motif from the remaining forkhead domain is a functionally essential step for initiating the neoplastic process. This hypothesis is also substantiated by results obtained in leukemias with a t(10;11)(p12q23) and t(11;17)(q23;q21) and their respective MLL/AF10 or MLL/AF17 hybrid genes. All breakpoints analysed so far disrupt the zinc ®nger and leucine-zipper motifs of the AF10 and AF17 genes (Chaplin et al., 1995b) , and thus result in the separation of these two motifs in the respective hybrid proteins.
Whether the partial homology of the amino-terminal part of AFX with the myb DNA-binding protein is functionally important remains open. The myb-gene family consists of three members, the c-myb protooncogene and two myb-related proteins. The c-myb gene encodes a transactivator that is essential for the proliferation of most hematopoietic precursor cells and its expression is largely restricted to those cells. However, various types of cycling cells express the myb-related proteins A and B. The latter is clearly regulated in a cell-cycle dependent manner and has recently been linked to the late G 1 to S phase transition (Lin et al., 1994) . It also seems to be important for the dierentiation of neuroblastoma cells (Raschella et al., 1995) . Interestingly, Southern blot analysis of a panel of rodent-human hybrid DNA's revealed that the Bmyb gene also maps to Xq13 (Barletta et al., 1991) .
Two other members of the forkhead gene family also have been linked to the development of neoplasia. The avian sarcoma virus 31 has a forkhead gene called qin. The qin oncogene is closely related to the Brain factor 1, a teleencephalon-speci®c forkhead gene (Li et al., 1993) . Furthermore, as already pointed out earlier, the forkhead domain of AFX is highly homologous to the FKHR protein, the gene of which is aected by the t(2;13)(q35;q14) found in alveolar rhabdomyosarcomas. This translocation fuses the PAX3 gene at chromosome 2(q35) to the FKHR gene at chromosome 13(q14). It is noteworthy that the fusion of FKHR and AFX with their corresponding partner genes PAX3 or MLL, respectively, occurs at identical amino acid positions. Moreover, in accordance with the AFX gene, the FKHR gene contains also a QIYEWM peptide motif upstream of the breakpoint. The PAX3/FKHR fusion protein is a more potent transcriptional activator than the normal PAX3 protein (Fredericks et al., 1995) . Although the transcriptional potential of MLL might be augmented by the forkhead protein of AFX in a similar fashion, this possiblity is in contrast to current beliefs which suggest that the various MLL rearrangements diminish or destroy the function of the MLL protein. . The notion that the various fusion partners of the MLL gene are similarly important for the transformation process as the MLL gene, is supported by the recent ®nding that that AF10 gene also fuses to another gene, CALM, in cases of translocation t(10;11)(p13;q14) (Dreyling et al., 1995) .
To date, the speci®c physiologic role of the known MLL partner proteins has been speci®ed for the ELL protein only. The ELL gene at chromosome 19p13.1 encodes for a RNA polymerase II elongation factor providing further evidence that deregulation of transcription and neoplastic cell growth are closely related phenomena (Shilatifard et al., 1996) .
The maintenance of the reading frame facilitates the transcription of the MLL/AFX and AFX/MLL hybrid genes on both the derivative chromosomes. Although both hybrid m-RNAs can be regularly found also in other instances of MLL rearrangements, according to current notion the critical oncogenic event is the fusion of the aminoterminal part of MLL to the carboxyterminus of the partner proteins (Rowley, 1992; Bernard et al., 1995) .
The amino acid sequence of the AFX protein as determined by us diers signi®cantly from the partial 3'-sequence reported by Parry et al. (Parry et al., 1994) . In this partial protein sequence the open reading frame shifts after 53 amino acids (corresponding to amino acid number 200 of our sequence). Based on the simple exon/intron structure of the AFX gene, we consider it rather unlikely that alternative splicing of the AFX gene may account for this sequence diversity. We rather believe that a sequencing error at nucleotide number 783 resulted in the loss of a cytosine residue. Moreover, a second reading shift 20 amino acids downstream suggest an oversight of the guanosine residue at position 844. Except for the amino acid Figure 7 Comparison of the partial forkhead domain amino acid sequence with that of several other members of this gene family. FKHR, human forkhead protein; qin, avian sarcoma virus 31 oncogene; HNF3alph/gamm, hepatocyte nuclear factor 3 alpha and gamma; BF1, brain factor-1; slp2, sloppy paired 2; DFKH, drosophila forkhead gene. Amino acid sequences were taken from Hromas and Costa (1995) . Note the ®ve amino acid insert (SNSSA) that is only present in the FKHR and the AFX gene numbers 174, 183, 228, and 243 the rest of our AFX protein sequence is in line with that of Corral et al. (1993) . The reason for the discrepancies in these four positions are not clear.
Materials and methods
Cell line and patient sample
The KARPAS 45 cell line a kind gift from A Karpas at the University of Cambridge, England, was established from a boy with T-cell acute lymphoblastic leukemia (Karpas et al., 1977) . The presence of a t(X;11)(q13;q23) and an AFX/ MLL rearrangement in this cell line had been established previously by FISH analysis and RT ± PCR, respectively. The patient's material was obtained from a 7 month old boy with ANLL and a complex t(X;11). The cytogenetic details of this case have been reported previously (Nacheva et al., 1982) .
Rapid ampli®cation of cDNA ends (RACE) and nucleotide sequencing RACE was performed with the help of the`Marathon cDNA ampli®cation kit' using nested PCR according to the manufacturers instructions (Clontech, Palo Alto, CA).
For the 3'-RACE PCR, a KSPI recognition site was added to the previously described internal sense primer for the MLL gene (Borkhardt et al., 1994) . The unspeci®c adapter primers AP1 and AP2 (AP1, 5'-CCATCCTAATACGACT-CACTATAGGGC-3', AP2, 5'-ACTCACTATAGGGCTC-GAGCGGC-3') were provided by the manufacturers. The adaptor contains recognition sites for NotI and XmaI (sticky ends) and Srf I (blunt ends). We used the KSPI and NotI site for the subsequent cloning of the PCRproduct into a Bluescript vector (Stratage, La Jolla, CA). The nested 5'-RACE PCR protocol was performed with two AFX antisense primers extern 5'-AGGGCTGCCT-GACCACTTGGCAAAGTGGCCG-3', intern 5'-GCACC-GCGGGCACC TTCGGGTGGAGC TGGCAGCACAGA-3'). The internal AFX antisense primers carried also a KSPI recognition site. We chose the clones with the largest inserts for subsequent nucleotide sequencing. Plasmid preparations were subjected to dideoxy sequencing (Sanger et al., 1977) with an automatic DNA sequencer (model ABI 373A, Perkin Elmer, Division Applied Biosystems, Foster City, CA).
Sequence homology scans were performed with the PC/ GENE computer software (Intelligenetics, Geneva) and the software package`Husar 4.0' at the European Molecular Biology Laboratory, Heidelberg.
Ampli®cation of MLL/AFX and AFX/MLL fusion sequences at the genomic and at the c-DNA level For the isolation of RNA and DNA we used the guanidium-isothiocyanate method and the ion exchange chromatography (Chomczynski et al., 1987; Sambrock et al., 1989) . For RT ± PCR we denatured 5 mg of total RNA at 708C for 5 min. cDNA synthesis was carried out at 428C for 60 min with 100 pmol of hexamers in a volume of 20 ml. To improve the sensitivity and the speci®city, we used nested PCR for ampli®cations of both the MLL/AFX and the AFX/MLL hybrid genomic DNA and cDNA. For the ampli®cation of the genomic DNA we applied a longrange PCR protocol (Cheng et al., 1994) . For the ampli®cation of MLL/AFX we designed PCR primers that are located in exon 8 of the MLL gene (sense extern, 5'-ATGTGTGGGAGATGGGAGGCTTAGGAATCTTG-3'; sense intern 5'-GCTTTCTCTGTGCCAGTAGTGGG-CATGTAG-3') and exon 2 of the AFX gene (antisense extern 5'-ACCTTCGGGTGGAGCTGGCAGCACAGAT-GG-3'; antisense intern, 5'-CGGAGCAGCTTGCTGCT-GCTATCCATGGAGG-3'). After an initial melting step for 1 min at 948C, ampli®cation was carried out for 28 cycles with denaturation at 948C for 10 s, annealing and strand extension for 10 min at 688C with a time extension for 15 s in the last 12 cycles. For ampli®cation of AFX/ MLL, we used the same protocol with two AFX sense primers (extern, 5'-GCCGGAATGCCTGGGGAAATCA-GTCATATGCAG-3'; intern, 5'-CGTACTGTACCCTAC-TTCAAGGACAAGGGTG-3') and two ML antisense primers (extern, 5'-CACTGTGCATCCCACCCTTTGCC-TGGAGTTG-3'; intern 5'-TGGATCCACAGCTCTTA-CAGCGAACACACTTGG-3') located in exon 1 of AFX and exon 11 of MLL, respectively. The conditions of the RT ± PCR for analysis of the MLL/AFX and AFX/MLL mRNA expression were reported previously (Borkhardt et al., 1994) .
Analysis of the AFX exon/intron structure and sequencing of AFX intron 1
The exon/intron structure of the AFX gene was determined with cDNA and genomic DNA obtained from a healthy volunteer and the promyelocytic cell line HL60. The PCRprimer sequences were as follows: 1. A1, AFX exon 1, sense 5'-ACTGTGGCAGGCTTCACTGAACGCTGAG-3'; 2. A2, AFX exon 1 antisense 5'-AAGTAGGGTACAG-TACGGACCATCCACTCG-3'; 3. B1, AFX exon 1 sense, 5' -CGTACTGTACCCTACTTCAAGGACAAGGGTG-3'; 4. B2, AFX exon 2 antisense, 5'-CGGAGCAGCTTG-CTGCTGCTATCCATGGAGG-3'; 5. C1, AFX exon 2 sense, 5'-CTGCACAGCAAGTTCATCAAGGTTCACA-ACG-3'; 6. C2, AFX exon 2 antisense, 5'-ACACACAC-TTCCACATAACCCCTGCAGTCAGG-3'. The intron 1 of the AFX gene was ampli®ed by primers B1 and B2 and sequenced as described above.
Semiquantitative RT ± PCR for measurement of AFX mRNA expression in normal B-and T-cells
Isolation of CD19
+ B-lymphocytes and CD2 + T-lymphocytes from mononuclear blood cells of ®ve healthy volunteers was performed with the help of magnetic beads according to the manufacturers protocol (Dynal, Oslo, Norway). 1610 5 cells from each sample were serially diluted by tenfold steps. Subsequently, the isolation of RNA and the cDNA synthesis was done as descibed above. We used the intron spanning primers B1 and B2 for ampli®cation of the cDNA in 25 PCR-cycles. The PCR product was subjected to agarose gel electrophoresis and semiquantitatively measured by ethidium bromide staining.
Fluorescent in situ hybridization (FISH)
FISH analysis was performed according to standard procedures with ®ve pooled clones named AFX 12, 15, 106, 108, 114 that were labeled with digoxigenine-11dUTP (Boehringer Mannheim, Germany) by nick translation. Digoxigenine-11dUTP was detected with mouse anti-digoxin and tetramethyl-rhodamine-isothiocyanate (TRITC) conjugated rabbit anti-mouse monoclonal antibodies (Sigma, Germany). The slides were counterstained with 4,6-diamino-2-phenylindole (DAPI) (Sigma, Germany), airdried and imbedded with H-1000 mounting medium (Vectashield, USA). The slides were analysed with a ZEISS-Axiophot uorescence microscope and an Vysis image analysis system.
